Clinical Trial Update: IRIS Followed by mFOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating sequencing of IRIS and mFOLFOX6 in advanced/metastatic colorectal cancer is currently suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• IRIS regimen (irinotecan + S-1)
• mFOLFOX6 regimen

Snippet

Sponsor: Hokkaido Gastrointestinal Cancer Study Group | Conditions: Metastatic Colorectal Cancer | Phase 3 | Status: SUSPENDED